For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Penn Live
Harrisburg is taking a wrong approach to drug pricing | PennLive letters
CEI’s Joel Zinberg was cited in a Penn Live article on Pharmacy Benefit Managers: Joel Zinberg from the Competitive Enterprise Institute (CEI) explains, “PBMs enhance…
Politico
Biden’s got a plan to protect science from Trump
CEI’s Joel Zinberg was cited in Politico on the obstacles Trump faces with the NIH: Trump should have no illusions about what he’s up against,…
Blog
New FDA lab tests rule could bankrupt small labs
Yesterday the Food and Drug Administration (FDA) announced that on May 6 it will promulgate a rule under its authority to regulate medical devices.
Search Posts
The New York Post
Team Biden’s Latest Welfare Expansion: Medicaid Payments for Housing, Food, even Furniture
Co-authored by Dr. Joel Zinberg and Gary Alexander The latest front in the Biden administration’s crusade to bypass the congressional appropriations process and expand the…
National Review
The CDC’s Premature Childhood-Vaccine Decision
The Centers for Disease Control and Prevention has proven once again how tone-deaf it is. The CDC’s independent Advisory Committee on Immunization Practices (ACIP) voted 15–0…
Wall Street Journal
The Bivalent Booster Boondoggle
The public-health bureaucracy is adopting yet another excessive vaccination policy. On Oct. 12 the Food and Drug Administration authorized bivalent Covid-19 boosters from …
Wall Street Journal
The Bivalent Booster Boondoggle
The public-health bureaucracy is adopting yet another excessive vaccination policy. On Oct. 12 the Food and Drug Administration authorized bivalent Covid-19 boosters from …
Blog
One Year on, FDA Sodium Guidance Still Wanting
It is the one year anniversary of the Food and Drug Administration’s (FDA) Guidance for Industry setting out goals to reduce sodium content in…
New York Post
California Makes it Illegal for Doctors to Disagree with Politicians
Conformity of thought is now required whether it is online, on college campuses, or, if you are in California, in a physician-patient relationship. PayPal recently…